Clinical Trial Update: Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the DTaP-IPV-Hep B-PRP-T combined vaccine to CombAct-HIB given with Engerix B Paediatric and OPV; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Haemophilus Influenzae Type Disease
• Hepatitis B
• Pertussis
• Poliomyelitis

Drugs mentioned

• CombAct-HIB (Haemophilus influenzae type b conjugate vaccine)
• DTaP-IPV-Hep B-PRP~T Combined Vaccine
• Engerix B Paediatric (Hepatitis B vaccine)
• OPV (Oral polio vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Hepatitis B, Polio | Phase 3 | Status: COMPLETED | Results posted: 2014-05-02